We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byJustin Daniels
Modified over 3 years ago
Solange Arazi Caillaud. MD Emiliano Bissio. MD María Ester Lázaro. MD
99% of men love Football 99% of what she says about us, is unfortunatly true Less than 30% of argentines dance tango 80% of argentines drink mate
Total Population 40 Millions HIV infected 120 000 People who know their HIV status 60 000 (50%) People on follow up 56 000 69% public health 31% security system
DISTRIBUTION OF HIV INFECTED PATIENTS ARGENTINA- 2008 Buenos Aires city and suburbs: 44% Central Area: 27%
Routes of transmission Argentina (2005-2008) MenWomen 48% 34% 87%
CD4 Viral load Resistance test PCR-HIV(MTCT) ARV Drugs for treatment and prophylaxis of opportunistic infections NRTI Zidovudine Lamivudine Stavudine Didanosine Tenofovir Abacavir Emtricitabine+ tenofovir NNRTI Nevirapine Efavirenz Etravirine PI Nelfinavir Indinavir Ritonavir Saquinavir Amprenavir Lopinavir+ritonavir Fosamprenavir Tipranavir Atazanavir Darunavir Integrase Inhibitor Raltegravir Co-Receptor antagonist Maraviroc Fusion Inhibitor Enfuvirtide ( T20)
Rate of MTCT per 10000 newborn Age at diagnosis of the children perinatally infected. N= 3898 67% 2 years old Number of children Age (years)
Thanks EACS for this great oportunity!
© IAS–USA Johnson VA et al. Top Antivir Med. 2011;19(4): Updates, user notes, and references available at Mutations in the.
© IAS–USA Johnson VA et al. Top Antivir Med. 2013;21(1):4-12. Updates, user notes, and references available at Mutations in the Reverse.
Antiretroviral targets in the viral life cycle Viral Replication and Drug targets.
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Dr Emmanuel Nsutebu Consultant Infectious Diseases Physician Tropical and Infectious Diseases Unit Royal Liverpool Hospital HIV “Myths, controversies and.
ANTIRETROVIRAL RESISTANCE Jennifer Fulcher, MD, PhD.
Medicines Patent Pool and Seychelles A primer For more information visit:
HIV Situation in India Dr Sunil Gaikwad.
HIV: WHAT IS NEW? DR NYA EBAMA, M.D. LOWCOUNTRY INFECTIOUS DISEASES, PA CARETEAM PLUS, INC SEPTEMBER 18, 2015.
ARV failure and resistance for the paediatrician
ANTIRETROVIRAL THERAPY Dr. Samuel Mwaniki (BPharm., MSc TID, UoN) University of Nairobi ISO 9001: Certified
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 94 Antiviral Agents II: Drugs for HIV Infection and.
The Medicines Patent Pool advancing innovation, expanding access, promoting public health Charles Clift Chair, Medicines Patent Pool
After completing this session the participant should be able to: Discuss the goals of HIV treatment. Understand when resistance testing should be.
HIV Care 2010: The 3 rd Revolution in HIV treatment Chris Farnitano, MD Noon Conference February 11, 2010.
Ministry of Health Health Surveillance Secretariat NATIONAL STD/AIDS PROGRAMME.
HIV/AIDS in Argentina Vanesa Fridman, MD Infectious Disease Hospital de Clinicas Universidad de Buenos Aires, Argentina.
ANTIVIRAL THERAPY DR FATAI OLUYADI USMLEINCLINED.COM 1.
Presented by: Siti Rohaizah bt Othman. Arv DRUGS AVAILABLE IN UMMC Combivir (Lamivudine + Zidovudine) Stocrin (Efavirenz 600mg) Kaletra (Lopinavir 200mg.
© 2017 SlidePlayer.com Inc. All rights reserved.